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Abstract: Increasingly, in major hospitals invasive monitoring endpoints are utilised to guide the acute resuscitation 
of burns. The aim of this review is to evaluate effects of invasive monitoring for major burns patients (>20% total 
body surface area) to prevent early organ dysfunction. Five databases were searched for randomised controlled 
trials and cohort studies that evaluated invasive monitoring within the acute phase (first 24 hours). Invasive monitor-
ing included transesophageal echocardiogram, central venous pressure measurement, and pulmonary artery cath-
eterisation. Primary outcomes included multiple organ failure scores, renal and cardiac dysfunction measurements, 
compartment syndrome and lactate at 24 hours. Secondary outcomes included mortality and intensive care unit 
stay. Ten studies involving 401 major burns patients were included. Data pooled from four studies demonstrated 
significantly improved cardiac index at 24 hours compared to non-invasive endpoints (MD: 0.65, 95% CI: 0.46-0.82, 
P=0.00001). Five studies pooled showed significantly increased urine output with invasive monitoring (MD: 0.18, 
95% CI: 0.03-0.34, P=0.02), whereas there was no difference in blood lactate levels (MD: -0.11, 95% CI: -0.44-0.22, 
P=0.43). There was a trend for lower mortality in invasive monitoring groups compared with non-invasive controls; 
however, the difference was not significant. There remains insufficient evidence to determine whether invasive 
monitoring to guide fluid resuscitation improves patient outcomes after major burn trauma. Although meta-analysis 
determined significantly improved cardiac index and urine output, further studies are required.
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Introduction
Globally 11 million people suffer from burns 
each year, and over 300,000 will die [1, 2]. 
Death primarily occurs from burns shock within 
72 hours [3] as a result of a decrease in blood 
volume from fluid loss, systemic inflammation, 
coagulopathy and organ dysfunction, particu-
larly cardiovascular and renal dysfunction [4, 
5]. Non-fatal burn injuries are also a leading 
cause of morbidity [6, 7]. Fluid resuscitation is 
the mainstay of treatment for burns in the 
acute phase after injury. The goal of fluid resus-
citation is to preserve organ function while 
avoiding complications such as compartment 
syndrome and pulmonary oedema from exces-
sive fluid administration [8]. Optimising the bal-
ance of fluid requirements in major burns 
patients is the goal of current research into the 
volume, type and endpoint of fluid resuscita-
tion. The modified Parkland formula with a tar-
geted urine output of >0.5 ml/kg/hr has tradi-
tionally been considered the standard of care 
in the acute resuscitation of burns [9-11]. 
However, hourly urine output in burns resuscita-
tion has been found to have no survival advan-
tage over the use of hemodynamic monitoring 
[12]. With the advancement of invasive hemo-
dynamic monitoring in critical care such as 
transpulmonary thermodilution (TPTD) and 
transoesophageal echocardiogram, it has 
potential application for resuscitation in the 
acute phase of burns [13-15]. In the intensive 
care setting TPTD and echocardiogram allow for 
multiple endpoints of cardiac function to be 
quantified [16]. TPTD commonly uses a Pulse 
Index Continuous Cardiac Output (PICCO) sys-
tem (Pulsion Medical Systems SE, Munich, 
Germany) or the Lithium Dilution Cardiac Output 
(LiDCO™) system (LiDCO Ltd., Cambridge, UK), 
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that measures mean arterial pressure (MAP), 
Cardiac output (CO)/Cardiac index (CI), Systemic 
Vascular Resistance Index (SVRI), end-diastolic 
volume (EDV), and extravascular lung water 
index (EVLWI) [14, 16]. The use of echocardio-
gram in fluid resuscitation allows for monitoring 
of changes in ventricular EDV and central 
venous pressure (CVP), and measurement of 
the inferior vena cava (IVC) diameter to assess 
volume status [17]. Although invasive monitor-
ing provides a range of vital parameters for 
goal-directed resuscitation, it has not been vali-
dated in burns patients, and to date, no sys-
tematic reviews have been completed on the 
subject. To address this gap, we conducted a 
systematic review and meta-analysis to identify 
the effect of early invasive monitoring of 
patients with major burns (>20% total body sur-
face area) on goal-directed resuscitation to pre-
serve organ function. This review provides sum-
mary results of the use of invasive monitoring 
in the acute setting of burns (first 24 hours) and 
its effect on organ dysfunction and mortality.
Materials and methods
Systematic review 
This systematic review was conducted and is 
reported using the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses 
(PRISMA) guideline [18]. A review protocol was 
registered and published with PROSPERO (reg-
istration number: CRD42018105269), an inter-
national prospective register for systematic 
reviews.
Eligibility criteria
All studies of major burns fluid resuscitation 
that used invasive monitoring during the acute 
resuscitation of major burns were included. 
Primary outcome measures of organ dysfunc-
tion in the first 24 hours were organ dysfunc-
tion score, renal or cardiac dysfunction, blood 
lactate levels, and abdominal compartment 
syndrome. The detailed search strategy is out-
lined in Appendix 1. Secondary outcome mea-
sures included mortality and length of stay 
(LOS) in the intensive care unit (ICU). This review 
defined acute intervention as the first 24 hours 
post-burn; if a time point was not specified all 
attempts to contact the author(s) were made to 
determine timing. Only studies that reported 
fluid resuscitation of burns covering a surface 
area greater than 20% in adult patients were 
included. There were no restrictions placed on 
study size, language, or date of publication. 
Animal studies, case studies, review articles 
and conference abstracts were excluded from 
this review.
Information sources 
The literature search was conducted on publi-
cations available up to January 4, 2019. Five 
databases were searched: Scopus (1996- 
present), MEDLINE (1946-present), EMBASE 
(1947-present), ClinicalTrials.gov, and Coch- 
rane. Reference lists of studies that were 
retrieved in full text were also hand searched to 
identify any additional studies. Where possible, 
the authors of the included studies were con-
tacted to find additional papers and unpub-
lished data.
Study selection
After duplicate studies were removed, two 
investigators screened the titles and abstracts 
of all retrieved citations to identify studies that 
potentially met the inclusion criteria. Studies 
judged relevant were retrieved in full text and 
were further reviewed by the same two investi-
gators for inclusion and relevance. The full text 
of any studies for which a definite decision 
could not be made from the title and abstract 
alone was also retrieved. If any disagreement 
about the eligibility of certain studies could not 
be decided a third investigator was consulted 
to determine its eligibility. 
Data extraction and analysis
Two investigators extracted the necessary 
information from identified papers using a stan-
dard form developed specifically for this review. 
Data were extracted for: General characteris-
tics (authors, year, title, journal, type of publica-
tion), Study characteristics (study design, sam-
ple size), Patient characteristics (age, gender, 
ethnicity, location, weight), Injury characteris-
tics (blast injury, scald, flame, thermal burn, 
fire, inhalation), Clinical characteristics (total 
body surface area [TBSA as a %], burn depth, 
delay time until resuscitation), Intervention 
type (invasive technique for monitoring, proto-
col used to determine resuscitation, fluid type, 
fluid volume), Outcome data that was reported 
at 24 hours (organ dysfunction, renal function, 
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cardiac function, abdominal compartment syn-
drome, blood lactate levels), as well as mortali-
ty and length of ICU stay. Summary statistics 
were extracted when available. There was a 
propensity for studies that included a wide 
range of major burn from 15-80% TBSA togeth-
er, and no differential of the timing of fluid 
administered (4-48 hours); wherever possible, 
only the data for resuscitation in the first 24 
hours with a major burn (>20%) are shown; 
however, this was not possible in all cases. 
Data are presented as mean ± standard devia-
tion unless otherwise indicated, and rbiostatis-
tics.com was used for conversion of descriptive 
statistics.
Quality assessment 
An adapted Newcastle-Ottawa tool for quanti-
tative research was adopted for the quality 
assessment (http://www.ohri.ca/programs/cli- 
nical_epidemiology/oxford.asp). Our tool in- 
cluded assessments of the following study 
characteristics: patient population source and 
suitability, surface area calculation (formula/
charts), research methodology, reported sam-
ple size calculation, data collection, range of 
%TBSA included/excluded in the study, whether 
validated tools were used to measure organ 
dysfunction, and whether time to initiate treat-
ment of burns injury was measured and report-
ed in a reliable manner. Each study was 
assessed as low, moderate, or high quality. 
Assessment of risk of bias
Two independent reviewers assessed the risk 
of bias of each included study using the 
Cochrane collaboration tool (http://hand-
book-5-1.cochrane.org). Evaluation of possible 
bias included generation and concealment of 
the allocation sequence, blinding, incomplete 
outcome data, selective outcome reporting and 
other sources of bias, with each criterion 
assessed as high risk, low risk, or unclear risk. 
In cases of disagreement the two review 
authors discussed the assessment until a 
shared decision was reached. Publication bias 
was planned using funnel plots if there was 
sufficient studies (N≥10) to explore systematic 
heterogeneity.
Meta-analysis method  
The meta-analysis was conducted in accor-
dance with the Meta-Analysis of Observational 
Studies in Epidemiology Group guidelines [19]. 
All computations were performed using the 
Review Manager version 5.3 statistical so- 
ftware (https://community.cochrane.org/help/
tools-and-software/revman-5). Due to multiple 
endpoints across a small number of studies a 
combined analysis of randomised controlled tri-
als (RCT) and observational studies was con-
ducted. The outcome measures analysed were: 
(1) urine output (UO) at 24 hours as a measure 
of kidney function; (2) cardiac index (CI) at 24 
hours as a measure of cardiac function; (3) 
blood lactate at 24 hours as a measure of tis-
sue hypoxia; and (4) mortality. Due to anticipat-
ed small sample size and differences in the 
invasive monitoring technique across studies, a 
random effects meta-analysis was undertaken 
to account for inherited variability. The mean 
difference of continuous primary outcomes of 
organ dysfunction (UO, CI, and lactate) and the 
relative risk for the secondary outcome (mortal-
ity) with associated 95% confidence intervals 
are reported. Statistical heterogeneity was 
determined by a statistically significant Chi2 
(P<0.05), and using the I2 statistic (I2<25%, low 
heterogeneity; I2=25-50%, moderate hete- 
rogeneity; I2>50%, substantial heterogeneity) 
(http://handbook-5-1.cochrane.org). Statistical 
significance was defined at the conventional 
5% level. 
Results
The initial databases search produced 1,712 
articles, leaving 1,382 unique articles when 
duplicates were removed (Figure 1). In total, 51 
articles were examined in full text, after titles 
and abstracts were screened. No additional 
articles were obtained through contact with the 
authors and no new articles were obtained 
through reference list searching. Based on our 
eligibility criteria, we included 10 studies involv-
ing 401 major burns patients (Table 1). All 10 
studies investigated the use of the invasive 
TPTD monitoring for goal-directed resuscita-
tion. No studies were identified that used echo-
cardiogram to guide fluid resuscitation. All 10 
studies were relatively small with number of 
participants ranging between N=24 and 
N=132, and two studies [20, 21] were observa-
tional cohort studies without a control group 
(Table 1). Eight studies remained for meta-
analysis, however not all studies reported all 
outcome measures. 
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Quality and bias assessment
Quality assessment showed nine medium qual-
ity and one low quality study (Table 2). From 10 
included studies, there were five RCTs [22-26], 
three prospective cohort studies [21, 27, 28], 
one retrospective cohort study [20], and one 
retrospective case series [29] (Table 1). Four 
studies determined sample size using a priori 
power analysis [23-26]. Only two studies, Foldi 
(2009) [24] and Csontos (2008) [25], stated a 
method for calculating the total body surface 
area burned using the Lund-Browder chart. Two 
studies included patients with severe burns 
[21, 29], with Chen primarily studying severe 
burns (>80% TBSA) [29]. All other studies 
excluded burns patients that were predicted 
not to survive the acute phase, with one study 
excluding patients if death occurred in the first 
seven days [24]. By combining RCTs and cohort 
studies in the review there is an increased risk 
of bias, however individual studies had a low 
level of bias. 
sive monitoring groups compared to the control 
group (Table 3).
Multiple organ failure
No study included in this review reported sig-
nificant differences in the organ dysfunction 
score in the first 24 hours. Since there was no 
standard definition of multiple organ failure 
used across the studies, no valid comparisons 
could be made and no original data were tabu-
lated in this review. Soussi (2016) [20] reported 
a lower sequential organ failure assessment 
(SOFA) score on day one (mean 3; range 1-4), 
compared to Sánchez (2013) [21] (4.38±3.09), 
while Tokarik (2013) [22] found no significant 
difference between invasive monitoring and 
control groups at 24 hours (Invasive: 5±1 vs. 
Control: 5±2; P=0.9). Foldi (2010) [23] and 
Csontos (2008) [25] reported a multiple organ 
dysfunction score (MODS) at 24 hours and 
reported no statistical differences (Foldi, 2010: 
Invasive: 3.5 (3.0-5.0); Control: 4.0 (2.0-5.0) 
Figure 1. PRISMA flow-chart. A total of 1382 studies were evaluated for ef-
fects of invasive monitoring endpoints in fluid resuscitation of major burns 
patients. Titles and abstracts were assessed, and 51 full-text articles were 
eligible for evaluation. 41 articles were excluded, and 10 articles remained 
for the systematic review. 
General information of study 
population
The average age of the study 
population ranged from 30.4 
to 52.9 years old, with a maxi-
mum age of 96 years in the 
study of Holm (2004) [26] 
(Table 3). Seven studies re- 
ported sex distribution with 
males predominant in all stud-
ies (65-92%). All studies had a 
mean TBSA>31.1%, with no 
reported differences in the 
TBSA between control and 
invasive monitoring groups in 
any study (Table 3). All 10 
studies administered crystal-
loid fluid for resuscitation, 
with four studies also using 
colloids within the first 24 
hours post-burn (Table 3). 
Three studies which used the 
intrathoracic blood volume 
index (ITBVI) to guide resusci-
tation had significantly higher 
rates of fluid administration 
(ml/kg/TBSA%) in the first 24 
hours [23-25], whereas Chen 
(2017) [29] and Arlati (2006) 
[28] reported significantly 
lower fluid rates in their inva-
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and Csontos, 2008: Invasive: 3.5 (3.0-5.0); 
Control: 4.0 (2.0-5.0)). 
Renal function
No studies reported renal function as per the 
Acute Kidney Injury Network (AKIN) criteria 
[30], nor did any study report creatinine levels. 
Urine output at 24 hours was reported in five 
studies [22-25, 28] (Table 4). Three of the stud-
ies reported significantly increased urine out-
put in the first 24 hours with invasive monitor-
ing [23-25] while there was no difference in the 
Tokarik study [22]. In contrast Arlati (2006) [28] 
reported a lower urine output in the invasive 
monitoring group, however this result was not 
significant and this study employed a fluid 
restrictive protocol (Table 4). A meta-analysis 
of the five studies reporting urine output at 24 
hours found a statistically significant difference 
between invasive monitoring compared to non-
invasive controls (MD: 0.18, 95% CI: 0.03-0.34, 
P=0.02), but there was substantial heterogene-
ity (P=0.0001, I2: 83%) (Figure 2).
Cardiac function
At least one measure of cardiac function was 
reported in all studies, with seven studies 
reporting cardiac index [21, 23-25, 27, 28] 
Table 1. Summary of study characteristics
Author, year Study design
Patients  
(Control:Invasive) Control definition Invasive endpoint definition
Chen, 2017 [29] Retrospective 
case series 
34 (21:13) PLA General Hospital formula* PICCO: CVP: 8-12 cm H20; MAP: >65 mmHg; UO: 
>1 ml/kg/hr; EVLWI: 3-7 ml/kg
Soussi, 2016 [20] Retrospective 
cohort 
40 No control PICCO: MAP: >65 mmHg; UO: 0.5-1 ml/kg/hr; CI: 
2.5-3 L/min/m2; ScvO2: >70%
Aboelatta, 2013 [27] Prospective 
cohort
30 (15:15) Modified Parkland: 3 ml × 
TBSA% × kg
PICCO: ITBVI: >800 ml/m2; CI: >3.5 L/min/m2
Sánchez, 2013 [21] Prospective 
cohort
132 No control PICCO: ITBVI: 600-1000 ml/m2; CI: >2.5 L/min/
m2
Tokarik, 2013 [22] RCT 21 (11:10) Brooke/Parkland: 3/4 ml × 
TBSA% × kg; UO: >0.5 ml/kg/hr 
LiDCO: MAP: >65 mmHg; UO: >0.5 ml/kg/hr; 
Variation systolic BP: >10 mmHg; Variation pulse 
pressure: >15%; Variation stroke volume: >15%  
Foldi, 2010 [23] RCT 30 (15:15) UO: >0.5-1 ml/kg/hr PICCO: ITBVI: 800-850 ml/m2 
Foldi, 2009 [24] RCT 16 (8:8) UO: >0.5-1 ml/kg/hr PICCO: ITBVI: 800-850 ml/m2
Csontos, 2008 [25] RCT 24 (12:12) UO: >0.5 ml/kg/hr PULSIOCATH: ITBVI: 800-850 ml/m2 
Arlati, 2006 [28] Prospective 
cohort 
24 (12:12) Parkland: 4 ml × TBSA% × kg PICCO: CI: 2.2 L/min/m2; CVP: <4 mmHg; UO: 
0.5-1 ml/kg/hr; MAP: >70 mmHg 
Holm, 2004 [26] RCT 50 (25:25) UO: >0.5 ml/kg/hr; MAP: >70 
mmHg; CVP: 2 cm H2O
COLD: ITBVI: >800 ml/m2; CI: >3.5 L/min/m2 
RCT = randomised controlled trial; TBSA = total burn surface area; UO = urine output; MAP = mean arterial pressure; BP = Blood pressure; CVP = central venous pres-
sure; PICCO = Pulse Index Continuous Cardiac Output; LiDCO: Lithium Dilution Cardiac Output; EVLWI: extravascular lung water index; CI = cardiac index; ScvO2 = central 
venous oxygen saturation; ITBVI = intrathoracic blood volume index. *not defined.
Table 2. Quality and risk assessment





Modified Ottawa Score 
(Oxford level of evidence)
Chen, 2017 [29] <6 h No No No 16/23 (4)
Soussi, 2016 [20] <8 h No Yes No 19/23 (2b)
Aboelatta, 2013 [27] <6 h No Yes No 18/23 (2b)
Sánchez, 2013 [21] <8 h No No Yes 16/23 (2b)
Tokarik, 2013 [22] <24 h No Yes No 15/23 (2b)
Foldi, 2010 [23] <3 h No Yes No 17/23 (2b)
Foldi, 2009 [24] <3 h Yes Yes No 18/23 (2b)
Csontos, 2008 [25] <3 h Yes Yes No 19/23 (2b)
Arlati, 2006 [28] <6 h No Yes No 18/23 (2b)
Holm, 2004 [26] <6 h No Yes No 19/23 (2b)
Time frame for inclusion defined as time between burn injury and initiation of fluid resuscitation. SA = surface area. Modified 
Ottawa score (≤15 low, 16-19 moderate, ≥20 high). Oxford level of evidence (http://www.ohri.ca/programs/clinical_epidemiol-
ogy/oxford.asp).
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Table 3. General characteristics of the study population





Fluid type used 
in first 24 hours
Mean Total volume 
over 24 hour (L)
Mean fluid rate in 24 
hours (ml/kg/TBSA%)
Mean Total volume 
over 24 hour (L)
Mean fluid rate in 24 
hours (ml/kg/TBSA%)
I C I C
Chen, 2017 [29] I: 31.7 N/R I: 88.7±3.6 N/R Crystalloid Colloid N/R N/R N/R N/R
C: 33.0 C: 86.1±6.2
Soussi, 2016 [20] 46.9±6.5# 65% 42.5±8.1# Inhalation LR Albumin N/R N/R N/R N/R
Aboelatta, 2013 [27] I: 30.4±15.2 N/R I: 41.1±10.9 N/R LR 16.3±5.4** 12.3±4.4 16.3±5.4** 12.3±4.4
C: 34.7±10.9 C: 38.7±8.8
Sánchez, 2013 [21] 48±18 74% 35.0±22.1 Inhalation Flame Elec-
trical Other trauma
LR HES N/R NA N/R NA
Tokarik, 2013^ [22] I: 48.5±13.9# N/R I: 32.4±15.2# Inhalation Crystalloid Colloid 6.8±0.8 9.7±1.4 6.8±0.8 9.7±1.4
C: 47±15.2# C: 35.5±16.1#
Foldi, 2010 [23] I: 52.9±16.0# 80% I: 45.9±8.7# Flame LR N/R N/R N/R N/R
C: 49.6±12.8# C: 44.9± 9.9#
Foldi, 2009 [24] I: 52.5±18.4# 81% I: 40.1±10.7# Flame LR N/R N/R N/R N/R
C: 48.9±17.3# C: 41.7±10.8#
Csontos, 2008 [25] 48.6±6.8# 92% I: 46±10# N/R LR N/R N/R N/R N/R
C: 41.8±10.1#
Arlati, 2006 [28] I: 40±14 88% I: 48±22 Flame Explosion 
Other
LR HES 7.5±5.4* 12.0±4.7 7.5±5.4* 12.0±4.7
C: 47±17 C: 49±22
Holm, 2004 [26] 48.5±21.5# 76% 46.4±16.2# Thermal Inhalation LR 27.1† (12-44) 16.2† (8-33) 27.1† (12-44) 16.2† (8-33)
Mean age and %TBSA for Invasive monitoring and control presented; if not available, overall mean presented. ^From Erratum [39]. #Converted from Median (Interquartile range) to mean for comparison. †Presented as mean and (range). 
*P<0.05 compared to control group. **P<0.0001. C: control group, I: invasive monitoring group, N/R: Not reported, NA: Not applicable, HES = hydroxyethyl starch, LR: Lactated Ringers.
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(Table 5). Holm et al found a statistical differ-
ence in cardiac index at 24 hours between inva-
sive and control groups (P<0.05), however 
exact values were unable to be determined 
from the available figure [26]. Aboelatta (2013) 
and Sánchez (2013) only reported mean cardi-
ac indices for invasive monitoring of 2.9 and 
3.22±1.12 L/min/m2, respectively [21, 27]. 
Four studies remained for meta-analysis that 
found invasive monitoring groups had signifi-
cantly higher cardiac index at 24 hr compared 
to non-invasive endpoints (MD: 0.65, 95% CI: 
0.47-0.82, P=0.00001, I2=46%) (Figure 3). 
Other measures of cardiac function were 
extracted however there was insufficient data 
to examine these indices including ITBVI and 
MAP across studies. Chen (2017) reported a 
MAP over the 48 hours study period and 
showed no difference between groups (P< 
0.05) [29]. Sánchez (2013) performed echocar-
diogram on hospital admission to determine 
the initial degree of volaemia, however this 
information was not stated to be part of the 
resuscitation protocol [21].
Abdominal compartment syndrome
Two studies reported values of intra-abdominal 
pressure (IAP) as an indicator of abdominal 
compartment syndrome. The single cohort 
study by Sánchez [21] reported intra-abdomi-
nal pressure from invasive monitoring to be 
12.1±8.2 mmHg. The study by Tokarik [22] did 
not show a difference in IAP between the inva-
sive monitoring and control groups (11.2±0.4 
and 13.4±0.5 mmHg; P=0.4). Foldi (2010) 
reported no intra-abdominal compartment syn-
drome in either group, however no pressure val-
ues were given [23]. 
Blood lactate
Six studies in this series reported a lactate 
level at 24 hours [21, 23-26, 28]. Sánchez 
Eight studies reported mortality with the excep-
tion of Arlati et al, and Foldi (2009) which 
excluded patients that did not survive the first 
week (Table 7) [24, 28]. Soussi reported a 
90-day mortality rate of 42% (28-day mortality 
was 26%), with all cases attributed to sepsis-
related multiple organ failure [20]. Six studies 
were eligible for meta-analysis which found no 
significant difference in mortality between inva-
sive monitoring and control groups (OR: 0.59, 
95% CI: 0.29-1.18, P=0.14, I2=0%) (Figure 5). 
The mean length of ICU stay ranged from 24.6 
to 44.5 days, with no differences between inva-
sive monitoring and control groups (Table 7).
Discussion 
This systematic review and meta-analysis has 
compared invasive monitoring against stan-
dard formulas to guide the acute resuscitation 
of major burns (>20% TBSA). Although organ 
function scores were inconsistently reported, 
significant improvements in the cardiac index 
and urine output were found when invasive 
monitoring was used compared to control 
groups applying non-invasive endpoints. An 
improved cardiac output is essential for all 
organ function, including renal function [31]. 
Mortality rates were lower in the invasive moni-
toring group compared with non-invasive con-
trols, however, the difference did not reach sta-
tistical significance. Other measurements col-
lected including lactate levels at 24 hours were 
similar in both groups, while abdominal com-
partment syndrome was under-reported. 
One of the primary challenges in the acute 
resuscitation of burns is the balance between 
over- and under-resuscitation [8, 32]. Invasive 
monitoring can accurately assess the hemody-
namic status of patients with burns, however 
the translation of invasive monitoring to 
improved outcomes of organ function in these 
(2013) [21] reported a mean lactate of 
2.45±1.78 mmol/L, with no control 
for comparison, leaving five studies 
for meta-analysis (Table 6). There was 
no statistical difference between lac-
tate levels at 24 hours for invasive 
monitoring compared to groups using 
non-invasive endpoints (MD: -0.11, 
95% CI: 0.44-0.22, P=0.43, I2=0%) 
(Figure 4).  
Mortality and length of ICU stay 





Tokarik, 2013 [22] 0.8±0.1 0.8±0.2 0.9
Foldi, 2010 [23] 1.1 (0.9-1.3)* 0.8 (0.6-1.1)* <0.05
Foldi, 2009 [24] 1.1 (0.9-1.3)* 0.7 (0.5-1.1)* <0.05
Csontos, 2008 [25] 1.1 (0.9-1.4)* 0.8 (0.6-1.0)* 0.0008
Arlati, 2006 [28] 1.0±0.4 1.3±0.6 NS
UO: urine output. Results reported as mean ± standard deviation or 
median (IQR)*.
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patients is mixed. All studies used different 
endpoints that included cardiac index, ITBVI, 
MAP and EVLWI, measured against traditional 
outcome measures, such as urine output. Our 
combined data suggest that there is limited evi-
dence to date of the improvement in organ 
function or prevention of organ dysfunction in 
the first 24 hours as a result of invasive 
monitoring.  
Although urine output was found to be signifi-
cantly improved with invasive monitoring, this 
result must be interpreted with caution in the 
context of kidney dysfunction, as it does not 
necessarily reflect an acute kidney injury (AKI) 
[33]. This requires assessment of other renal 
parameters such as creatinine [34, 35]. The 
incidence of AKI in burn patients is as high as 
43%, and therefore, this is a key area to target 
to improve patient outcomes [32, 33]. AKI in 
the acute setting can occur due to under-
resuscitation and is associated with increased 
mortality [32, 33]. Measuring and reporting AKI 
during the acute phase post-burn better reflects 
the effects of under-resuscitation, whereas 
studies that report kidney function parameters 
at a later time point may reflect development of 
sizes (<100 patients) and inconsistent report-
ing of organ function. Furthermore, many stud-
ies excluded severely burnt patients (>85% 
TBSA) and/or those not expected to live beyond 
48 hours and thus were excluded from our 
review. It is highly recommended that this group 
of patients should not be excluded when evalu-
ating resuscitation, and sub-analyses should 
be considered given the importance of tighter 
control of resuscitation for these patients [37]. 
The mechanism of injury is also an important 
parameter to differentiate, as patients with 
electrical injuries require greater volumes of 
fluid administration than do patients with ther-
mal burns and should be included in a separate 
analysis [38].
In the current guidelines for resuscitation of 
major burns patients, urine output is used to 
titrate fluid requirement, however more studies 
are required to investigate the most accurate 
endpoint of resuscitation [9, 10]. As previously 
mentioned, urine output has not shown ade-
quate evidence to protect organ function [12]. 
Another major gap in intensive care of patients 
with burns discovered in this review is the lack 
of standard invasive monitoring endpoints, 
sepsis, multi-organ failure, fluid over-
load or the use of nephrotoxic drugs 
[36].
The strength of this review is that it 
presents a comprehensive overview 
of all reported multi-organ function 
measurements that have been 
investigated in the acute resuscita-
tion of major burns when invasive 
monitoring has been compared to 
traditional endpoints. The included 
studies had primarily small sample 
Figure 2. Urine output at 24 hours. CI: confidence interval. I2: test of heterogeneity. The forest plot shows the mean 
difference calculated by the random effects model. Squares represent individual study effects and diamonds repre-
sent the summary effect from the meta-analysis. Horizontal bars represent 95% CIs and the vertical line in the MD 
plot is at 0, corresponding to the null hypothesis of no effect.





Aboelatta, 2013 [27] 2.9 Not stated
Sánchez, 2013 [21] 3.22±1.12 No control
Foldi, 2010 [23] 3.6 (3.3-3.9)* 2.8 (2.4-3.2)* <0.05
Foldi, 2009 [24] 3.5 (3.2-3.9)* 2.9 (2.3-3.5)* <0.05
Csontos, 2008 [25] 3.5 (3.3-3.8)* 3.0 (2.4-3.5)* 0.013
Arlati, 2006 [28] 3.4±0.7 3.1±0.7 NS
Results reported as mean ± standard deviation or median (IQR)*.
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which may have contributed to the heterogene-
ity found in the primary outcome measures. 
Conclusion 
Implications for practice
Currently, there is limited evidence on the ben-
efits of invasive monitoring to guide fluid resus-
citation in patients after severe burn trauma. 
Pooled data across multiple studies showed 
significant improvements in cardiac index and 
urine output when invasive monitoring was 
used compared to control groups. Further stud-
ies on the application of invasive monitoring in 
major burns patients may lead to improve-
ments in patient outcomes as well as the estab-
lishment of evidence-based guidelines for goal-
directed resuscitation using invasive monitor-
ing. Multiple factors influence morbidity and 
mortality across lengthy hospital stays for 
major burns patients. For a more accurate 
understanding of the impact of resuscitation 
practices and organ function, studies need to 
measure and report organ function as a routine 
practice using validated metrics and measures 
burns patients. Future studies must implement 
appropriate randomisation methods, sample 
size and adequate blinding of clinicians to the 
outcome assessed. An ongoing challenge is 
having access to sufficient numbers of patients 
with similar burn injuries of different severities 
to accurately evaluate fluid resuscitation and 
the association with organ dysfunction. This 
could be achieved in a multi-centre trial involv-
ing a number of countries, as part of the data 
collection. Once more clinical information is 
obtained, there is also the question on whether 
implementation of new protocols can replace 
traditional formulas with careful titration by 
experienced healthcare staff.
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Sánchez, 2013 [21] 2.45±1.78 No comparison
Foldi, 2010 [23] 2.3 (1.6-3.6)* 2.6 (1.5-3.7)* NS
Foldi, 2009 [24] 2.3 (1.4-4.7)* 2.5 (1.6-3.5)* NS
Csontos, 2008 [25] 2.3 (1.3-4.7)* 2.4 (1.7-3.6)* NS
Arlati, 2006 [28] 1.97±1.24 3.23±2.25 NS
Holm, 2004 [26] 4.1±3.3 4.8±2.9 NS
Results reported as mean ± standard deviation or median (IQR)* NS: not 
significant.
in both the acute phase and long-
term follow-up.   
Implications for research
A clinically important question re- 
mains on whether invasive monitor-
ing can improve the outcomes of 
major burns when used to guide 
fluid resuscitation. High-quality pro-
spective randomised controlled tri-
als are required to address this 
issue, that report early effects on 
organ function across all major 
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Appendix 1: Search strategies
MEDLINE and Embase search strategy using Ovid SP
‘Burn’ 
‘kidney failure’ OR ‘kidney’ OR ‘abdominal disease’ OR ‘multiple organ failure’ OR ‘organ dysfunction 
score’ OR abdom* OR ‘sequential organ failure assessment score’ OR ‘urine volume’ OR ‘gastric 
tonometry’ OR ‘acute kidney failure’ OR ‘bladder pressure’ OR ‘apache’ OR ‘cardiovascular disease’ OR 
‘respiratory tract disease’ OR ‘lactate dehydrogenase’
‘transesophageal echocardiography’ OR ‘TOE’ OR ‘echocardiography’ OR ‘hemodynamic monitoring’ OR 
‘hemodynamics’ OR ‘cardiovascular monitoring device’ OR ‘cardiac output monitor’
‘human’/de 
Scopus search strategy
(TITLE-ABS-KEY (burn*) AND NOT TITLE-ABS-KEY (“burning sensation”)) 
(“kidney” OR “abdom*” OR “organ failure” OR “MOF” OR “SOFA” OR “urine volume” OR “gastric 
tonometry” OR “AKI” OR “bladder*” OR “apache” OR “cardiac” OR “respiratory” OR “lactate”)
“transesophageal echocardiography” OR “TOE” OR “echo*” OR “hemodynamic*” OR “ITBVI”) 
(LIMIT-TO (EXACTKEYWORD, “Human”))
